| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |